In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 

Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Shares of Danaher popped more than 7% on Tuesday after the life sciences company delivered beats across its three main businesses — a sign the long-awaited turnaround in the biotech industry is finally here.